HTGC Stock Recent News

Hercules Capital's dividend coverage is robust, with NII covering 125% of the base dividend and 106% of the aggregate payout. The BDC is growing its investment portfolio rapidly, with record origination volumes and a conservative debt-to-equity ratio of 0.97x. Fed rate cuts are likely to pressure net income, making dividend safety and portfolio growth key differentiators among BDCs.

Hercules Capital remains a top BDC pick due to consistent net investment income growth, robust dividend coverage, and exceptional balance sheet quality. Despite trading at a significant premium to NAV, strong fundamentals and record gross fundings in Q2 2025 justify the valuation and support future dividend growth potential. The investment firm excels in the technology and life science sectors, maintaining one of the industry's lowest non-accrual rates and making net interest margin gains in Q2.

HTGC's BBB+ credit rating with stable outlook gets affirmed by KBRA, backed by a strong portfolio, risk management and capital access.

SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Kroll Bond Rating Agency, Inc. (“KBRA”) has affirmed Hercules' investment grade corporate and credit rating of BBB+. KBRA issued a statement announcing the affirmation.

We take a look at the action in business development companies through the first week of August and highlight some of the key themes we are watching. BDCs underperformed despite strong early earnings, with sector valuations dipping below historical averages. Tight lending spreads continue to pressure BDC net income.

Business Development Companies offer income-focused investors access to big-yield private credit opportunities, traded on the public market. Hercules Capital is a standout among the group for its differentiated strategy, consistent long-term growth, and big quarterly dividend payments to investors. This report reviews Hercules' business strategy, growth, dividend safety, valuation, and risks, and then concludes with my strong opinion on investing.

CARY, N.C. , Aug. 8, 2025 Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the completion of a comprehensive capital restructuring designed to enhance the Company's financial flexibility, reduce total debt, and support long-term growth. The multi-faceted refinancing transaction consisted of the following key components: A new senior credit facility with Hercules Capital, Inc. (NYSE: HTGC), due in 2030, which provides $110.0 million in committed capital at closing and an additional $40.0 million in two $20.0 million tranches available upon achievement of certain milestones, to be drawn at the Company's discretion; An exchange agreement with the existing holder of Heron's 1.5% senior convertible notes due 2026 to retire outstanding principal, including repayment of approximately $125.0 million in cash and conversion of $25.0 million into common stock; Issuance and sale of $35.0 million of new 5.0% senior conve

LOS ANGELES--(BUSINESS WIRE)--Snappt, the leading platform for applicant trust in multifamily housing, today announced it has acquired Trigo, a company known for its breakthrough technology in verifying rental payment history. Backed by a $50 million committed facility from Hercules Capital, Inc. (NYSE: HTGC), the acquisition expands Snappt's platform and strengthens its ability to help property managers make faster, more confident leasing decisions. Together, these milestones mark a major step.

Relatively higher rates and lingering tariff-related headwinds will affect demand for personalized financing. Yet, Zacks SBIC & Commercial Finance industry players like ARCC, MAIN and HTGC are worth a look.

The BDC investment at HTGC represents one of the best options for investors who want to generate long-term income. Q2 results beat expectations, with $0.50 NII covering the $0.47 dividend and confirming payout sustainability. The stock demonstrates powerful upward movement which could lead to new historical price highs.